Signaling pathways
-
BA6534 CFT1946Summary: CFT1946 is an orally active, CRBN-based mutation-selective bifunctional degradation-activating compound (BiDAC) degrader with a DC of 14 nM in A375 cells. -
BA6535 TinlorafenibSummary: Tinlorafenib (PF-07284890) is an orally effective inhibitor.
-
BA6536 GNE-9815Summary: GNE-9815 (Compound 7) is a highly selective pan-type inhibitor with good oral bioavailability.
-
BA6537 PLX7922Summary: PLX7922 is an inhibitor that binds to BRAFV600E.
-
BA6538 TBAP-001Summary: TBAP-001 is a pan-inhibitor of kinases.
-
BA6539 LUT014Summary: LUT014 is an inhibitor.
-
BA6540 KG5Summary: KG5 is an orally active dual and variant inhibitor.
-
BA6542 PF-04880594Summary: PF-04880594 is a potent and selective inhibitor.
-
BA6543 M2698Summary: M2698 (MSC2363318A) is an orally active, ATP-competitive, selective and dual inhibitor.
-
BA6544 RSK4-IN-1Summary: RSK4-IN-1 is a potent inhibitor.